▁Introduction 7.855957508087158
: 1.9071056842803955
<0x0A> 6.521755695343018
M 4.660501956939697
el 4.492181777954102
an 2.7295281887054443
oma 0.3398086130619049
▁is 0.42351892590522766
▁an 3.260802745819092
▁ag 0.8648306727409363
gress 0.0019312064396217465
ive 0.006047617644071579
▁form 1.369965672492981
▁of 0.003780229249969125
▁skin 0.13920560479164124
▁cancer 0.006861930247396231
▁that 0.9176596403121948
▁can 1.523944616317749
▁met 3.8631796836853027
ast 0.003717289539054036
as 0.01127411425113678
ize 0.03407091274857521
▁rapidly 3.658267021179199
▁if 2.739586114883423
▁left 1.1217970848083496
▁un 0.06334136426448822
tre 0.05914834514260292
ated 0.00013519247295334935
. 0.10867209732532501
▁Over 5.446924209594727
▁the 0.6562067866325378
▁years 2.127734899520874
, 0.11533521860837936
▁adv 4.248757839202881
anc 1.1315586566925049
ements 8.046950824791566e-05
▁in 0.137306809425354
▁medical 2.5862555503845215
▁science 2.061147689819336
▁have 0.2971716523170471
▁led 1.4110361337661743
▁to 0.012470372021198273
▁the 0.9929566383361816
▁development 0.2449662834405899
▁of 0.010332795791327953
▁ground 6.9993510246276855
bre 0.40982988476753235
aking 1.776234057615511e-05
▁treat 0.937882661819458
ments 0.00017924723215401173
, 2.347383737564087
▁not 6.986148834228516
ably 0.37589070200920105
▁imm 1.1093014478683472
une 2.755772113800049
▁check 0.14841800928115845
point 0.005441243294626474
▁in 0.13220325112342834
hib 7.128969446057454e-05
itors 0.06709948927164078
▁and 2.901188373565674
▁adj 4.811708450317383
uv 0.02017994038760662
ant 0.029954632744193077
▁ther 0.4625692367553711
ap 0.8460357189178467
ies 0.00019021650950890034
. 0.5207871198654175
▁These 1.764064073562622
▁novel 3.7484261989593506
▁approaches 1.7974910736083984
▁have 0.4109991788864136
▁shown 2.793177843093872
▁great 2.758970022201538
▁potential 2.1782753467559814
▁in 0.093935027718544
▁ach 6.028988838195801
ieving 2.3365293600363657e-05
▁long 1.6784722805023193
- 0.006232450716197491
term 0.12876765429973602
▁rem 0.7971068620681763
ission 0.11948969960212708
▁and 0.8780181407928467
▁impro 1.3785334825515747
ving 0.0008603458409197628
▁surv 1.6448967456817627
ival 0.003832881571725011
▁rates 0.2889120578765869
▁for 1.2875170707702637
▁patients 0.6079381704330444
▁at 6.369643211364746
▁different 3.836413860321045
▁stages 0.05636778473854065
▁of 0.0766712948679924
▁mel 0.8596494793891907
an 5.5076208809623495e-05
oma 0.000676145195029676
. 0.21363189816474915
▁This 2.472102165222168
▁ess 3.6861467361450195
ay 0.0003194127057213336
▁a 1.7977367639541626
ims 2.062341991404537e-05
▁to 0.005900351330637932
▁discuss 2.301287889480591
▁the 0.3128458559513092
▁adv 4.989948272705078
anc 0.2735983431339264
ements 4.172412081970833e-05
▁in 0.3758513033390045
▁these 4.494082450866699
▁treat 0.9917102456092834
ments 2.8968277547392063e-05
, 1.1301348209381104
▁their 0.8577035069465637
▁imp 3.6758532524108887
lications 0.006240068003535271
▁for 0.5975391268730164
▁patients 1.4718438386917114
, 0.3393651247024536
▁and 0.041882239282131195
▁illustrate 12.66520881652832
▁their 1.3718825578689575
▁impact 2.16430926322937
▁on 0.07908550649881363
▁surv 3.070539951324463
ival 0.03395269811153412
▁rates 0.22183072566986084
▁through 4.997182846069336
▁the 2.851386070251465
▁case 3.0651440620422363
▁of 0.7359864115715027
▁Mr 3.920711040496826
. 0.07446315884590149
▁B 3.9850456714630127
. 0.8476654291152954
<0x0A> 0.15682265162467957
Ad 1.2110211849212646
van 1.0148811340332031
c 0.020116446539759636
ements 0.00026402383809909225
▁in 0.012851509265601635
▁Mel 1.8758904933929443
an 7.760825246805325e-05
oma 0.0002597311686258763
▁Tre 0.07500667124986649
at 4.184333374723792e-05
ment 0.6179832220077515
: 0.22822891175746918
<0x0A> 0.08870886266231537
Im 0.8892741203308105
m 0.17395755648612976
une 0.005412477068603039
▁check 0.3408971428871155
point 0.002168322214856744
▁in 0.005783021915704012
hib 8.583106136939023e-06
itors 0.008147558197379112
▁such 4.555953502655029
▁as 0.000709666172042489
▁p 1.8731017112731934
emb 0.003467963542789221
rol 0.0003931699029635638
iz 0.0005464258138090372
um 0.0005037861410528421
ab 0.00014365752576850355
▁and 0.8322478532791138
▁n 0.334665983915329
iv 0.0003613886365201324
ol 0.0008897566003724933
um 0.0010515614412724972
ab 0.00012148164387326688
▁have 0.41199058294296265
▁revolution 0.6180568933486938
ized 0.0029788832180202007
▁mel 1.8538914918899536
an 2.4080563889583573e-05
oma 9.477587445871904e-05
▁treatment 0.05535364896059036
. 0.8355200886726379
▁These 0.17018596827983856
▁dru 0.2369680553674698
gs 2.9802365588693647e-06
▁work 0.6682069897651672
▁by 0.0037933322601020336
▁blocking 0.5571162104606628
▁the 0.2848913371562958
▁interaction 1.5583490133285522
▁between 0.05030473321676254
▁cancer 4.6487298011779785
▁cells 0.02096092514693737
▁and 0.0027966827619820833
▁imm 0.7748067378997803
une 0.018707729876041412
▁in 5.920043468475342
hib 0.015246153809130192
itory 0.0987062156200409
▁mole 0.8282450437545776
cules 0.0019734888337552547
, 0.19822193682193756
▁thus 2.683767795562744
▁activ 2.39552903175354
ating 0.00010753256356110796
▁the 0.07454272359609604
▁imm 0.1705314815044403
une 8.118482219288126e-05
▁system 0.06336981058120728
▁to 0.43319064378738403
▁recognize 1.152061104774475
▁and 0.011607038788497448
▁eliminate 1.8989838361740112
▁cancer 0.5262187719345093
▁cells 0.09348451346158981
. 0.11863506585359573
▁They 4.176558494567871
▁have 0.19848628342151642
▁demonstrated 2.7327311038970947
▁remarkable 1.8921916484832764
▁success 1.4171398878097534
▁in 0.05079945921897888
▁ach 2.2865889072418213
ieving 0.0008753195288591087
▁dur 3.089228868484497
able 0.00020845916878897697
▁responses 1.6080458164215088
▁and 1.2374093532562256
▁prolong 1.532199740409851
ed 0.9956547021865845
▁surv 0.6665006875991821
ival 0.0021258522756397724
▁rates 1.3235936164855957
▁in 0.7211086750030518
▁met 3.7643892765045166
ast 0.00011182457092218101
atic 0.001464007655158639
▁mel 0.08083000779151917
an 1.5974172129062936e-05
oma 0.0012389941839501262
▁patients 0.43352338671684265
. 0.4987320899963379
<0x0A> 0.864482045173645
Add 4.168306827545166
itionally 0.00850469060242176
, 0.00014926116273272783
▁adj 0.5892724990844727
uv 0.00019009728566743433
ant 0.000438130518887192
▁ther 0.050052229315042496
ap 0.384146124124527
ies 1.3113029808664578e-06
, 1.9813052415847778
▁such 0.35084447264671326
▁as 6.389821646735072e-05
▁inter 2.3720128536224365
fer 0.3376903235912323
on 0.006061889696866274
▁ther 4.146836757659912
apy 0.015514960512518883
, 0.6846552491188049
▁target 3.1393930912017822
ed 1.9683196544647217
▁ther 0.09948381036520004
apy 0.6492184400558472
, 0.13685666024684906
▁and 0.09525534510612488
▁cancer 7.127527236938477
▁v 0.12239726632833481
acc 5.8175828598905355e-05
ines 0.05381820350885391
, 0.04157114028930664
▁have 0.3580157160758972
▁played 5.148673057556152
▁a 0.13740336894989014
▁p 4.071025848388672
iv 3.695494797284482e-06
otal 3.576279254957626e-07
▁role 0.000314285047352314
▁in 0.0007445603259839118
▁reducing 1.553860068321228
▁disease 4.1152448654174805
▁rec 0.3345654308795929
urrence 0.012415391393005848
▁and 0.5681811571121216
▁impro 0.15566428005695343
ving 1.776234057615511e-05
▁overall 1.3365747928619385
▁surv 0.095699742436409
ival 0.0002597311686258763
▁rates 0.3550594747066498
▁post 5.496107578277588
- 0.03544668108224869
s 0.26993823051452637
urg 2.3961352781043388e-05
ery 0.11049366742372513
. 0.0734548270702362
▁These 1.0694034099578857
▁ther 0.7797796726226807
ap 0.0001400807232130319
ies 5.960466182841628e-07
▁are 2.3552660942077637
▁often 2.8353445529937744
▁tail 5.83854866027832
ored 0.002181762596592307
▁to 0.07467316091060638
▁the 0.659643292427063
▁specific 0.9879292845726013
▁mole 1.9444891214370728
cular 0.001535163028165698
▁characteristics 1.852961540222168
▁of 0.013080178759992123
▁mel 4.992432594299316
an 3.4571290598250926e-05
oma 0.015794437378644943
, 1.0421030521392822
▁ens 2.7171478271484375
uring 2.3841887468734058e-06
▁a 3.389322280883789
▁patient 7.1797966957092285
- 0.5853077173233032
center 1.0592936277389526
ed 0.0001251775975106284
▁approach 0.048398327082395554
. 2.3491194248199463
<0x0A> 0.08441834151744843
Imp 1.5430115461349487
lications 0.09889412671327591
▁for 0.1102662980556488
▁Pat 0.0311221145093441
ients 0.007408156059682369
▁at 7.533709526062012
▁D 0.06555037945508957
ifferent 0.0004554235783871263
▁St 0.00832220260053873
ages 2.229238634754438e-05
: 1.2170439958572388
<0x0A> 0.004558985587209463
For 2.06681752204895
▁patients 0.09583349525928497
▁with 0.9411273002624512
▁early 0.7337369918823242
- 0.14781224727630615
stage 0.0012739067897200584
▁mel 0.036833614110946655
an 2.1219479094725102e-05
oma 0.0043484801426529884
, 0.0517607107758522
▁imm 3.383690595626831
une 0.7750676870346069
▁check 0.023483948782086372
point 0.004557788372039795
▁in 0.008665206842124462
hib 1.6689314179529902e-06
itors 0.01235154364258051
▁have 1.709010124206543
▁shown 1.0781428813934326
▁prom 1.2062935829162598
ising 4.255862222635187e-05
▁out 3.3676087856292725
comes 2.2053962311474606e-05
▁for 4.940652847290039
▁reducing 3.3854453563690186
▁the 0.4335828721523285
▁risk 0.05214200168848038
▁of 0.0008829556754790246
▁rec 0.7461995482444763
urrence 0.013894740492105484
. 0.7874849438667297
▁Studies 3.712347984313965
▁have 0.07114913314580917
▁shown 0.9829617738723755
▁that 0.039614446461200714
▁patients 1.8975766897201538
▁with 1.1929388046264648
▁Stage 3.694831609725952
▁III 2.2939300537109375
▁mel 0.8768393397331238
an 8.905330469133332e-05
oma 0.0030591143295168877
▁who 0.4164069890975952
▁receive 0.9985266327857971
▁adj 1.1095046997070312
uv 0.0016581446398049593
ant 7.736981933703646e-05
▁ther 0.7973213195800781
apy 0.1012147068977356
▁with 1.585548758506775
▁imm 1.251389980316162
une 0.07733378559350967
▁check 0.004721684381365776
point 0.004113420844078064
▁in 0.004824335686862469
hib 1.1920936913156766e-06
itors 0.0065848794765770435
▁experienced 6.510172367095947
▁significantly 2.0977087020874023
▁better 2.585357666015625
▁rec 4.273543357849121
urrence 0.00030391066684387624
- 0.1412370651960373
free 0.0007421743357554078
▁surv 0.07882297784090042
ival 0.0004064074601046741
▁compared 2.4050023555755615
▁to 0.02383219636976719
▁traditional 6.963695526123047
▁treat 2.267971992492676
ments 2.8849064619862475e-05
. 0.4615686535835266
▁This 3.0877466201782227
▁implies 3.9071667194366455
▁that 0.03129632771015167
▁these 1.673919439315796
▁ther 1.541725754737854
ap 0.00043824975728057325
ies 1.5497219010285335e-06
▁can 1.044574499130249
▁potentially 2.6018433570861816
▁convert 9.146378517150879
▁a 2.4401605129241943
▁dead 3.6815438270568848
ly 0.01219930313527584
▁disease 0.5080567002296448
▁into 0.08910280466079712
▁a 0.08193845301866531
▁manage 1.4867874383926392
able 3.7432415410876274e-05
▁condition 1.155994176864624
▁in 5.050896644592285
▁the 0.9391075372695923
▁long 0.6327915191650391
▁term 0.660359799861908
. 0.07864093035459518
<0x0A> 0.03865475580096245
In 2.6598458290100098
▁patients 1.8481067419052124
▁with 0.028232017531991005
▁advanced 0.7748821377754211
- 1.3826740980148315
stage 0.0012249697465449572
▁mel 0.09152810275554657
an 3.171017306158319e-05
oma 0.0013512556906789541
, 0.04477708414196968
▁imm 0.5902261137962341
une 0.0315832644701004
▁check 0.004601259250193834
point 0.0018179838079959154
▁in 0.0036038649268448353
hib 4.172333774477011e-06
itors 0.006660659797489643
▁have 0.42087745666503906
▁provided 4.3200907707214355
▁previously 7.909523963928223
▁un 0.045941729098558426
seen 2.1714634895324707
▁levels 2.0525970458984375
▁of 0.00022240966791287065
▁control 3.674058198928833
▁over 0.5511233806610107
▁the 0.2751006484031677
▁disease 0.07466011494398117
. 0.2517872154712677
▁The 3.0959815979003906
▁use 3.1071689128875732
▁of 0.00018520878802519292
▁p 2.8788681030273438
emb 0.011559401638805866
rol 0.00011146689939778298
iz 8.452295878669247e-05
um 0.0002945499145425856
ab 4.577741856337525e-05
▁has 1.7702546119689941
▁yield 5.025076389312744
ed 0.00014854580513201654
▁remarkable 2.2706680297851562
▁results 0.6001057028770447
, 0.5963712334632874
▁with 0.19664663076400757
▁studies 4.571939468383789
▁finding 4.883345127105713
▁that 0.24247942864894867
▁patients 1.7197086811065674
▁achieved 4.383401870727539
▁higher 4.928927421569824
▁objective 3.5149781703948975
▁response 0.15066038072109222
▁rates 0.009942501783370972
▁and 0.6150559186935425
▁longer 0.955721378326416
▁pro 0.7484920024871826
gression 2.5033982637978625e-06
- 0.0012463942402973771
free 0.00023802966461516917
▁surv 0.025515202432870865
ival 0.0008079095860011876
▁compared 0.8112648725509644
▁to 0.012059756554663181
▁conventional 3.0209970474243164
▁chem 1.8417233228683472
other 0.0016919373301789165
apy 0.09560570120811462
. 0.22575148940086365
▁This 1.831384539604187
▁offers 5.885600566864014
▁renew 4.223714828491211
ed 4.768485450767912e-05
▁hope 0.0058394367806613445
▁and 3.7154366970062256
▁prolong 4.417727947235107
ed 0.22064551711082458
▁surv 0.2968723177909851
ival 0.0045968289487063885
▁for 0.9221794009208679
▁individuals 3.5070390701293945
▁facing 2.577597141265869
▁advanced 1.527503490447998
▁mel 1.04036545753479
an 3.552499765646644e-05
oma 0.0009415408712811768
. 0.11457863450050354
<0x0A> 0.011560969054698944
The 2.2551352977752686
▁Case 0.7062260508537292
▁of 0.007864563725888729
▁Mr 0.0018290308071300387
. 0.0037997339386492968
▁B 0.0018311806488782167
: 0.06559327244758606
<0x0A> 0.045169491320848465
To 4.4031805992126465
▁illustrate 0.5063475966453552
▁the 0.04656761512160301
▁impact 0.2958480417728424
▁of 0.03005180135369301
▁imm 2.2127017974853516
une 0.026874952018260956
▁check 0.004581319633871317
point 0.0018272394081577659
▁in 0.003387519856914878
hib 3.337865791763761e-06
itors 0.026421168819069862
▁in 2.906548500061035
▁mel 1.2068004608154297
an 3.9220627513714135e-05
oma 9.9663928267546e-05
▁treatment 0.12568065524101257
, 0.01977490447461605
▁we 1.2757607698440552
▁can 1.092257022857666
▁examine 2.0821192264556885
▁Mr 2.9222288131713867
. 0.0019431503023952246
▁B 0.0031279318500310183
' 1.331117868423462
s 0.00032191688660532236
▁case 0.2946222424507141
. 0.13600468635559082
▁Mr 0.2582765817642212
. 0.0030048289336264133
▁B 0.0017483608098700643
▁was 0.8023442625999451
▁diagn 0.3035334646701813
osed 4.768382950715022e-06
▁with 0.0032404656521975994
▁met 1.979319453239441
ast 0.0001347155775874853
atic 0.0012723549734801054
▁mel 0.0531502403318882
an 2.8610638764803298e-05
oma 3.0041192076168954e-05
▁and 1.5146647691726685
▁was 1.657292127609253
▁initially 1.6565322875976562
▁respond 8.153202056884766
ing 0.004036994185298681
▁poor 4.868843078613281
ly 4.124726547161117e-05
▁to 0.0034274717327207327
▁traditional 1.4596871137619019
▁treat 0.818696916103363
ments 1.9908149624825455e-05
. 0.2528700828552246
▁However 0.8269901275634766
, 0.00016058780602179468
▁upon 2.398927927017212
▁starting 2.6765990257263184
▁p 1.4351730346679688
emb 0.0007034629816189408
rol 5.221503306529485e-05
iz 3.433286474319175e-05
um 0.0001847318490035832
ab 4.780406743520871e-05
▁ther 1.1807212829589844
apy 0.00011039389210054651
, 0.02979244291782379
▁his 1.1847578287124634
▁tum 0.8127522468566895
or 0.9425485730171204
▁re 5.259032726287842
gress 0.016926944255828857
ions 6.20828914642334
▁were 0.9957833290100098
▁observed 2.834768056869507
, 0.9335989952087402
▁leading 3.4396820068359375
▁to 0.009886336512863636
▁a 1.0444931983947754
▁dur 2.638828754425049
able 0.000439561641542241
▁response 0.5714994072914124
▁with 3.07639217376709
▁no 1.2970099449157715
▁disease 2.6086652278900146
▁pro 0.15297600626945496
gression 8.535749657312408e-05
. 1.46341872215271
<0x0A> 2.714179754257202
This 0.7981653213500977
▁case 0.48470109701156616
▁exempl 3.2467052936553955
ifies 0.004039089195430279
▁the 0.15298505127429962
▁potential 1.1733962297439575
▁of 0.12764713168144226
▁imm 0.13967552781105042
une 0.01731773279607296
▁check 0.005229833070188761
point 0.0022086435928940773
▁in 0.0040955254808068275
hib 1.4305124977909145e-06
itors 0.01128731481730938
▁in 0.32506826519966125
▁ach 0.8947281241416931
ieving 6.294449121924117e-05
▁long 0.20391371846199036
- 0.0009386771125718951
term 0.04155467823147774
▁rem 0.0980079248547554
ission 0.017336348071694374
▁for 2.1016454696655273
▁patients 0.5360565781593323
▁with 0.18797965347766876
▁advanced 0.5160889029502869
▁mel 0.3477938175201416
an 2.5630324671510607e-05
oma 0.0004055726167280227
. 0.04111051931977272
▁Mr 1.8631062507629395
. 0.0026432012673467398
▁B 0.0009300860110670328
' 0.16821782290935516
s 0.0001081286754924804
▁experience 1.7573063373565674
▁highlight 0.9080518484115601
s 0.0010739965364336967
▁how 3.3085033893585205
▁target 3.85986328125
ed 0.07853957265615463
▁ther 0.501001238822937
ap 0.18893420696258545
ies 4.291543518775143e-06
▁can 0.25831490755081177
▁effectively 3.2160181999206543
▁halt 4.721653461456299
▁disease 1.5301135778427124
▁pro 0.009338393807411194
gression 0.00012744283594656736
, 1.3990495204925537
▁extending 4.026707649230957
▁surv 1.0826870203018188
ival 0.002605252433568239
▁and 1.8525784015655518
▁impro 0.14594484865665436
ving 1.752391835907474e-05
▁the 2.1425585746765137
▁quality 0.3784410059452057
▁of 0.0002168055798392743
▁life 0.002612961921840906
▁for 0.16480204463005066
▁patients 0.719440221786499
▁facing 3.023200035095215
▁a 1.7171721458435059
▁previously 4.170505523681641
▁ble 5.7759318351745605
ak 0.00021740177180618048
▁pro 0.3089655935764313
gn 4.410753717820626e-06
osis 0.000142703705932945
. 0.005319712683558464
<0x0A> 0.0345107838511467
Con 2.889946699142456
clusion 0.18750162422657013
: 0.19777175784111023
<0x0A> 6.698705673217773
The 2.0207133293151855
▁adv 0.2312268614768982
anc 0.04442744702100754
ements 1.180178969661938e-05
▁in 0.012686396017670631
▁mel 0.21969126164913177
an 2.0861843950115144e-05
oma 1.9788936697295867e-05
▁treatment 0.0821552649140358
▁through 3.1651077270507812
▁imm 0.3816317915916443
une 0.009246828965842724
▁check 0.0010168355656787753
point 0.0014490251196548343
▁in 0.0010520387440919876
hib 2.3841860752327193e-07
itors 0.0037060421891510487
▁and 0.0530129037797451
▁adj 0.030963733792304993
uv 0.0004870885459240526
ant 0.0002901378902606666
▁ther 0.0010015614097937942
ap 0.009047243744134903
ies 6.7949522417620756e-06
▁have 0.21127116680145264
▁significantly 2.1025822162628174
▁transformed 2.3561291694641113
▁the 0.10780161619186401
▁pro 1.7826616764068604
gn 0.0008060007239691913
osis 0.00735801737755537
▁and 2.7248873710632324
▁quality 1.9530099630355835
▁of 0.0011431550374254584
▁life 0.010277451947331429
▁for 0.11592143028974533
▁patients 0.43347081542015076
▁at 2.59676194190979
▁different 0.18528848886489868
▁stages 0.002874269150197506
. 1.8033013343811035
▁Through 5.158759593963623
▁extensive 7.031815052032471
▁research 0.1870574653148651
▁and 0.29707974195480347
▁evidence 4.651468753814697
, 2.593641757965088
▁it 1.4984281063079834
▁is 0.2376004010438919
▁evident 0.619462788105011
▁that 0.0017646613996475935
▁these 0.09536968171596527
▁treat 0.9990506172180176
ments 8.344684829353355e-06
▁offer 1.7270690202713013
▁the 3.9513416290283203
▁potential 0.43147826194763184
▁for 1.0945203304290771
▁long 0.7757266163825989
- 0.0006722086691297591
term 0.030616315081715584
▁rem 0.0788654163479805
ission 0.0053610000759363174
, 1.580690622329712
▁particularly 5.960310935974121
▁when 4.851539611816406
▁combined 0.8495856523513794
▁with 0.025721220299601555
▁personal 4.087071418762207
ized 0.0010020387126132846
▁adj 5.574719429016113
uv 0.0006678546196781099
ant 0.002039245329797268
▁ther 0.05334297940135002
ap 0.20543551445007324
ies 8.344684829353355e-06
. 0.1717219352722168
▁As 1.8686283826828003
▁demonstrated 6.1930413246154785
▁by 0.7798227667808533
▁Mr 0.6755119562149048
. 0.0011788996635004878
▁B 0.0014339828630909324
' 0.03847659379243851
s 0.00010085614485433325
▁case 0.2270144522190094
, 0.019090039655566216
▁these 0.6962615251541138
▁adv 2.6150248050689697
anc 0.04715040326118469
ements 8.225475539802574e-06
▁bring 5.183061122894287
▁hope 0.3632306158542633
▁for 3.0255870819091797
▁patients 1.4428671598434448
▁facing 0.5937255620956421
▁advanced 1.0564943552017212
▁mel 0.2518261671066284
an 1.585496102052275e-05
oma 0.00037212143070064485
, 0.6888247132301331
▁prom 5.213118553161621
ising 0.8632920980453491
▁increased 4.890516757965088
▁surv 0.2202482521533966
ival 0.004651440307497978
▁rates 0.2507913410663605
▁and 0.10666659474372864
▁improved 0.2817033529281616
▁overall 3.0050294399261475
▁out 1.1640281677246094
comes 0.005051355343312025
. 0.03498010337352753
▁Cont 6.8551025390625
in 0.1596795916557312
ued 0.001239829696714878
▁research 0.2764306962490082
▁and 0.324709415435791
▁innov 1.4059321880340576
ation 0.08576270937919617
▁in 0.2960920035839081
▁this 0.8803465962409973
▁field 0.2075010985136032
▁hold 2.53692364692688
▁promise 2.4067230224609375
▁for 0.11242261528968811
▁further 1.1429295539855957
▁adv 1.2118172645568848
anc 0.07506784051656723
ements 1.2755474926962052e-05
, 2.3559389114379883
▁offering 2.828157901763916
▁hope 2.4969117641448975
▁to 1.3297340869903564
▁count 2.9383742809295654
less 4.7565637942170724e-05
▁individuals 0.1747003197669983
▁batt 2.379347324371338
ling 0.00023087543377187103
▁this 0.2427418977022171
▁ag 1.4684228897094727
gress 6.0917802329640836e-05
ive 1.776234057615511e-05
▁form 0.723788321018219
▁of 0.0003586458333302289
▁skin 1.2666188478469849
▁cancer 0.00020500138634815812
. 0.014141964726150036
